nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—PDE4D—breast cancer	0.156	0.413	CbGaD
Theophylline—CYP1B1—breast cancer	0.0971	0.257	CbGaD
Theophylline—CYP1A1—breast cancer	0.0524	0.139	CbGaD
Theophylline—CYP2D6—breast cancer	0.039	0.103	CbGaD
Theophylline—CYP3A4—breast cancer	0.0335	0.0885	CbGaD
Theophylline—CYP1A1—Toremifene—breast cancer	0.027	0.0746	CbGbCtD
Theophylline—CYP1B1—Tamoxifen—breast cancer	0.0225	0.0621	CbGbCtD
Theophylline—CYP1B1—Mitoxantrone—breast cancer	0.022	0.0606	CbGbCtD
Theophylline—CYP1B1—Paclitaxel—breast cancer	0.0175	0.0483	CbGbCtD
Theophylline—SLC22A7—Fluorouracil—breast cancer	0.015	0.0414	CbGbCtD
Theophylline—CYP1A2—Anastrozole—breast cancer	0.0132	0.0364	CbGbCtD
Theophylline—CYP1B1—Docetaxel—breast cancer	0.0127	0.0349	CbGbCtD
Theophylline—CYP1A2—Toremifene—breast cancer	0.0121	0.0333	CbGbCtD
Theophylline—CYP2C9—Anastrozole—breast cancer	0.0119	0.0328	CbGbCtD
Theophylline—SLC22A7—Docetaxel—breast cancer	0.0115	0.0316	CbGbCtD
Theophylline—CYP2C8—Lapatinib—breast cancer	0.0114	0.0314	CbGbCtD
Theophylline—CYP1A1—Tamoxifen—breast cancer	0.00988	0.0272	CbGbCtD
Theophylline—CYP1B1—Doxorubicin—breast cancer	0.00944	0.026	CbGbCtD
Theophylline—CYP3A4—Exemestane—breast cancer	0.00913	0.0252	CbGbCtD
Theophylline—CYP2C9—Idarubicin—breast cancer	0.00902	0.0249	CbGbCtD
Theophylline—CYP2C8—Raloxifene—breast cancer	0.00863	0.0238	CbGbCtD
Theophylline—SLC22A7—Methotrexate—breast cancer	0.00828	0.0228	CbGbCtD
Theophylline—CYP2D6—Idarubicin—breast cancer	0.00825	0.0227	CbGbCtD
Theophylline—CYP3A4—Letrozole—breast cancer	0.00776	0.0214	CbGbCtD
Theophylline—CYP2E1—Tamoxifen—breast cancer	0.00763	0.021	CbGbCtD
Theophylline—CYP2E1—Mitoxantrone—breast cancer	0.00744	0.0205	CbGbCtD
Theophylline—CYP3A4—Anastrozole—breast cancer	0.00692	0.0191	CbGbCtD
Theophylline—CYP3A4—Toremifene—breast cancer	0.00633	0.0175	CbGbCtD
Theophylline—CYP3A4—Fulvestrant—breast cancer	0.00588	0.0162	CbGbCtD
Theophylline—CYP2C8—Tamoxifen—breast cancer	0.0057	0.0157	CbGbCtD
Theophylline—CYP3A4—Thiotepa—breast cancer	0.00524	0.0145	CbGbCtD
Theophylline—CYP2C9—Capecitabine—breast cancer	0.00494	0.0136	CbGbCtD
Theophylline—CYP3A4—Ixabepilone—breast cancer	0.0048	0.0132	CbGbCtD
Theophylline—CYP3A4—Lapatinib—breast cancer	0.00462	0.0127	CbGbCtD
Theophylline—CYP2C8—Paclitaxel—breast cancer	0.00444	0.0122	CbGbCtD
Theophylline—CYP1A2—Tamoxifen—breast cancer	0.00441	0.0122	CbGbCtD
Theophylline—CYP2C8—Fluorouracil—breast cancer	0.0042	0.0116	CbGbCtD
Theophylline—CYP2D6—Vinorelbine—breast cancer	0.00403	0.0111	CbGbCtD
Theophylline—CYP2C9—Tamoxifen—breast cancer	0.00398	0.011	CbGbCtD
Theophylline—CYP2D6—Tamoxifen—breast cancer	0.00364	0.01	CbGbCtD
Theophylline—CYP3A4—Raloxifene—breast cancer	0.0035	0.00965	CbGbCtD
Theophylline—CYP1A2—Fluorouracil—breast cancer	0.00325	0.00897	CbGbCtD
Theophylline—CYP2C9—Paclitaxel—breast cancer	0.00309	0.00854	CbGbCtD
Theophylline—CYP2C9—Fluorouracil—breast cancer	0.00293	0.00808	CbGbCtD
Theophylline—CYP3A4—Vinorelbine—breast cancer	0.00256	0.00706	CbGbCtD
Theophylline—CYP2D6—Vinblastine—breast cancer	0.00248	0.00685	CbGbCtD
Theophylline—CYP3A4—Tamoxifen—breast cancer	0.00231	0.00638	CbGbCtD
Theophylline—CYP3A4—Mitoxantrone—breast cancer	0.00225	0.00622	CbGbCtD
Theophylline—CYP3A4—Paclitaxel—breast cancer	0.0018	0.00496	CbGbCtD
Theophylline—CYP3A4—Irinotecan—breast cancer	0.00178	0.0049	CbGbCtD
Theophylline—CYP3A4—Vinblastine—breast cancer	0.00158	0.00435	CbGbCtD
Theophylline—CYP2D6—Doxorubicin—breast cancer	0.00153	0.00421	CbGbCtD
Theophylline—CYP3A4—Docetaxel—breast cancer	0.0013	0.00359	CbGbCtD
Theophylline—PDE4A—mammary gland—breast cancer	0.00119	0.0301	CbGeAlD
Theophylline—ADORA2B—nipple—breast cancer	0.00111	0.0279	CbGeAlD
Theophylline—HDAC2—Gefitinib—Lapatinib—breast cancer	0.00108	0.579	CbGdCrCtD
Theophylline—CYP3A4—Doxorubicin—breast cancer	0.00097	0.00267	CbGbCtD
Theophylline—HDAC2—mammary gland—breast cancer	0.000949	0.024	CbGeAlD
Theophylline—HDAC2—Topotecan—Irinotecan—breast cancer	0.000787	0.42	CbGdCrCtD
Theophylline—PDE3B—pituitary gland—breast cancer	0.00073	0.0184	CbGeAlD
Theophylline—PDE3B—adipose tissue—breast cancer	0.000727	0.0183	CbGeAlD
Theophylline—PDE3B—adrenal gland—breast cancer	0.000652	0.0164	CbGeAlD
Theophylline—HDAC2—embryo—breast cancer	0.000648	0.0163	CbGeAlD
Theophylline—PDE3B—bone marrow—breast cancer	0.000631	0.0159	CbGeAlD
Theophylline—Caffeine—ATM—breast cancer	0.000626	0.166	CrCbGaD
Theophylline—CYP1B1—mammary gland—breast cancer	0.000609	0.0154	CbGeAlD
Theophylline—PDE4D—adipose tissue—breast cancer	0.000607	0.0153	CbGeAlD
Theophylline—ADORA2B—pituitary gland—breast cancer	0.000605	0.0153	CbGeAlD
Theophylline—ADORA2B—adipose tissue—breast cancer	0.000602	0.0152	CbGeAlD
Theophylline—PDE4B—nipple—breast cancer	0.000588	0.0148	CbGeAlD
Theophylline—Caffeine—PIK3CD—breast cancer	0.000572	0.152	CrCbGaD
Theophylline—Caffeine—PIK3CB—breast cancer	0.000572	0.152	CrCbGaD
Theophylline—PDE3B—endocrine gland—breast cancer	0.000565	0.0143	CbGeAlD
Theophylline—PDE5A—epithelium—breast cancer	0.000565	0.0142	CbGeAlD
Theophylline—ADA—adipose tissue—breast cancer	0.000551	0.0139	CbGeAlD
Theophylline—PDE4D—adrenal gland—breast cancer	0.000544	0.0137	CbGeAlD
Theophylline—PDE4A—adipose tissue—breast cancer	0.000537	0.0135	CbGeAlD
Theophylline—HDAC2—epithelium—breast cancer	0.000529	0.0133	CbGeAlD
Theophylline—PDE4D—female gonad—breast cancer	0.000507	0.0128	CbGeAlD
Theophylline—ADA—female reproductive system—breast cancer	0.000506	0.0128	CbGeAlD
Theophylline—HDAC2—skin of body—breast cancer	0.000503	0.0127	CbGeAlD
Theophylline—ADA—adrenal gland—breast cancer	0.000494	0.0125	CbGeAlD
Theophylline—Oxtriphylline—PDE4D—breast cancer	0.000486	0.129	CrCbGaD
Theophylline—PDE4A—adrenal gland—breast cancer	0.000481	0.0121	CbGeAlD
Theophylline—ADA—bone marrow—breast cancer	0.000478	0.0121	CbGeAlD
Theophylline—HDAC2—endometrium—breast cancer	0.000474	0.012	CbGeAlD
Theophylline—CYP2C8—mammary gland—breast cancer	0.000467	0.0118	CbGeAlD
Theophylline—ADORA2A—female reproductive system—breast cancer	0.000461	0.0116	CbGeAlD
Theophylline—PDE5A—adipose tissue—breast cancer	0.000456	0.0115	CbGeAlD
Theophylline—ADORA2A—adrenal gland—breast cancer	0.000449	0.0113	CbGeAlD
Theophylline—PDE4A—female gonad—breast cancer	0.000449	0.0113	CbGeAlD
Theophylline—PDE3A—adipose tissue—breast cancer	0.000444	0.0112	CbGeAlD
Theophylline—Caffeine—PIK3CA—breast cancer	0.000443	0.118	CrCbGaD
Theophylline—HDAC2—uterus—breast cancer	0.000437	0.011	CbGeAlD
Theophylline—ADORA1—adipose tissue—breast cancer	0.000433	0.0109	CbGeAlD
Theophylline—HDAC2—pituitary gland—breast cancer	0.000429	0.0108	CbGeAlD
Theophylline—ADA—endocrine gland—breast cancer	0.000428	0.0108	CbGeAlD
Theophylline—HDAC2—adipose tissue—breast cancer	0.000427	0.0108	CbGeAlD
Theophylline—PDE5A—female reproductive system—breast cancer	0.000419	0.0106	CbGeAlD
Theophylline—CYP2C9—mammary gland—breast cancer	0.000415	0.0105	CbGeAlD
Theophylline—Dyphylline—PDE4D—breast cancer	0.000414	0.11	CrCbGaD
Theophylline—PDE5A—adrenal gland—breast cancer	0.000409	0.0103	CbGeAlD
Theophylline—PDE3A—female reproductive system—breast cancer	0.000408	0.0103	CbGeAlD
Theophylline—PDE3A—adrenal gland—breast cancer	0.000398	0.01	CbGeAlD
Theophylline—ADORA1—female reproductive system—breast cancer	0.000398	0.01	CbGeAlD
Theophylline—HDAC2—female reproductive system—breast cancer	0.000393	0.00991	CbGeAlD
Theophylline—PDE3B—lymph node—breast cancer	0.000391	0.00986	CbGeAlD
Theophylline—ADORA2A—endocrine gland—breast cancer	0.00039	0.00983	CbGeAlD
Theophylline—SLC22A7—endocrine gland—breast cancer	0.000386	0.00974	CbGeAlD
Theophylline—HDAC2—adrenal gland—breast cancer	0.000383	0.00967	CbGeAlD
Theophylline—PDE5A—female gonad—breast cancer	0.000382	0.00963	CbGeAlD
Theophylline—PDE3A—female gonad—breast cancer	0.000371	0.00937	CbGeAlD
Theophylline—HDAC2—bone marrow—breast cancer	0.000371	0.00935	CbGeAlD
Theophylline—CYP1A2—nipple—breast cancer	0.000361	0.00911	CbGeAlD
Theophylline—HDAC2—female gonad—breast cancer	0.000357	0.00902	CbGeAlD
Theophylline—CYP1A1—nipple—breast cancer	0.000356	0.00899	CbGeAlD
Theophylline—PDE4B—endometrium—breast cancer	0.000355	0.00896	CbGeAlD
Theophylline—PDE5A—endocrine gland—breast cancer	0.000355	0.00895	CbGeAlD
Theophylline—PDE3A—endocrine gland—breast cancer	0.000345	0.00871	CbGeAlD
Theophylline—ADORA1—endocrine gland—breast cancer	0.000337	0.00849	CbGeAlD
Theophylline—HDAC2—endocrine gland—breast cancer	0.000332	0.00839	CbGeAlD
Theophylline—PDE4D—lymph node—breast cancer	0.000326	0.00823	CbGeAlD
Theophylline—CYP1B1—skin of body—breast cancer	0.000323	0.00814	CbGeAlD
Theophylline—PDE4B—pituitary gland—breast cancer	0.000321	0.00811	CbGeAlD
Theophylline—PDE4B—adipose tissue—breast cancer	0.00032	0.00807	CbGeAlD
Theophylline—ADA—lymph node—breast cancer	0.000296	0.00747	CbGeAlD
Theophylline—PDE4B—female reproductive system—breast cancer	0.000294	0.00742	CbGeAlD
Theophylline—PDE4A—lymph node—breast cancer	0.000289	0.00728	CbGeAlD
Theophylline—PDE4B—adrenal gland—breast cancer	0.000287	0.00724	CbGeAlD
Theophylline—CYP1B1—uterus—breast cancer	0.00028	0.00707	CbGeAlD
Theophylline—PDE4B—bone marrow—breast cancer	0.000278	0.00701	CbGeAlD
Theophylline—CYP1B1—pituitary gland—breast cancer	0.000275	0.00695	CbGeAlD
Theophylline—CYP1B1—adipose tissue—breast cancer	0.000274	0.00692	CbGeAlD
Theophylline—PDE4B—female gonad—breast cancer	0.000268	0.00675	CbGeAlD
Theophylline—CYP1B1—female reproductive system—breast cancer	0.000252	0.00636	CbGeAlD
Theophylline—PDE4B—endocrine gland—breast cancer	0.000249	0.00628	CbGeAlD
Theophylline—CYP1B1—adrenal gland—breast cancer	0.000246	0.00621	CbGeAlD
Theophylline—PDE5A—lymph node—breast cancer	0.000245	0.00619	CbGeAlD
Theophylline—CYP1A1—epithelium—breast cancer	0.00024	0.00605	CbGeAlD
Theophylline—PDE3A—lymph node—breast cancer	0.000239	0.00602	CbGeAlD
Theophylline—CYP2C8—endometrium—breast cancer	0.000233	0.00588	CbGeAlD
Theophylline—ADORA1—lymph node—breast cancer	0.000233	0.00587	CbGeAlD
Theophylline—HDAC2—lymph node—breast cancer	0.00023	0.0058	CbGeAlD
Theophylline—CYP1B1—female gonad—breast cancer	0.000229	0.00579	CbGeAlD
Theophylline—CYP1A1—skin of body—breast cancer	0.000228	0.00576	CbGeAlD
Theophylline—CYP1B1—endocrine gland—breast cancer	0.000213	0.00538	CbGeAlD
Theophylline—CYP2C8—pituitary gland—breast cancer	0.000211	0.00532	CbGeAlD
Theophylline—CYP1A1—uterus—breast cancer	0.000198	0.005	CbGeAlD
Theophylline—CYP1A1—adipose tissue—breast cancer	0.000194	0.00489	CbGeAlD
Theophylline—CYP2C8—female reproductive system—breast cancer	0.000193	0.00487	CbGeAlD
Theophylline—Aminophylline—CYP3A4—breast cancer	0.000182	0.0484	CrCbGaD
Theophylline—Caffeine—CYP1B1—breast cancer	0.00018	0.0479	CrCbGaD
Theophylline—CYP1A1—female reproductive system—breast cancer	0.000178	0.0045	CbGeAlD
Theophylline—PDE4B—lymph node—breast cancer	0.000172	0.00434	CbGeAlD
Theophylline—CYP2C9—female reproductive system—breast cancer	0.000171	0.00433	CbGeAlD
Theophylline—CYP2C8—endocrine gland—breast cancer	0.000163	0.00412	CbGeAlD
Theophylline—CYP2E1—female reproductive system—breast cancer	0.000163	0.0041	CbGeAlD
Theophylline—CYP1A1—female gonad—breast cancer	0.000162	0.00409	CbGeAlD
Theophylline—CYP2E1—adrenal gland—breast cancer	0.000159	0.004	CbGeAlD
Theophylline—CYP1A2—endocrine gland—breast cancer	0.000153	0.00386	CbGeAlD
Theophylline—CYP1A1—endocrine gland—breast cancer	0.000151	0.0038	CbGeAlD
Theophylline—CYP1B1—lymph node—breast cancer	0.000147	0.00372	CbGeAlD
Theophylline—CYP2C9—endocrine gland—breast cancer	0.000145	0.00366	CbGeAlD
Theophylline—CYP2E1—endocrine gland—breast cancer	0.000138	0.00347	CbGeAlD
Theophylline—CYP3A4—female reproductive system—breast cancer	0.000131	0.0033	CbGeAlD
Theophylline—CYP2D6—female reproductive system—breast cancer	0.000129	0.00325	CbGeAlD
Theophylline—CYP2D6—female gonad—breast cancer	0.000117	0.00295	CbGeAlD
Theophylline—CYP3A4—endocrine gland—breast cancer	0.000111	0.00279	CbGeAlD
Theophylline—CYP2D6—endocrine gland—breast cancer	0.000109	0.00275	CbGeAlD
Theophylline—CYP1A1—lymph node—breast cancer	0.000104	0.00263	CbGeAlD
Theophylline—Caffeine—CYP1A1—breast cancer	9.72e-05	0.0259	CrCbGaD
Theophylline—Caffeine—CYP2D6—breast cancer	7.24e-05	0.0193	CrCbGaD
Theophylline—Hypotension—Fluorouracil—breast cancer	6.81e-05	0.000659	CcSEcCtD
Theophylline—Rash—Tamoxifen—breast cancer	6.8e-05	0.000658	CcSEcCtD
Theophylline—Hypersensitivity—Vinorelbine—breast cancer	6.8e-05	0.000657	CcSEcCtD
Theophylline—Dermatitis—Tamoxifen—breast cancer	6.79e-05	0.000657	CcSEcCtD
Theophylline—Headache—Tamoxifen—breast cancer	6.76e-05	0.000653	CcSEcCtD
Theophylline—Palpitations—Paclitaxel—breast cancer	6.72e-05	0.00065	CcSEcCtD
Theophylline—Vomiting—Melphalan—breast cancer	6.71e-05	0.000649	CcSEcCtD
Theophylline—Insomnia—Gemcitabine—breast cancer	6.7e-05	0.000648	CcSEcCtD
Theophylline—Rash—Melphalan—breast cancer	6.66e-05	0.000644	CcSEcCtD
Theophylline—Flushing—Capecitabine—breast cancer	6.65e-05	0.000643	CcSEcCtD
Theophylline—Dermatitis—Melphalan—breast cancer	6.65e-05	0.000643	CcSEcCtD
Theophylline—Decreased appetite—Irinotecan—breast cancer	6.61e-05	0.00064	CcSEcCtD
Theophylline—Decreased appetite—Mitoxantrone—breast cancer	6.61e-05	0.00064	CcSEcCtD
Theophylline—Arrhythmia—Docetaxel—breast cancer	6.61e-05	0.00064	CcSEcCtD
Theophylline—Nausea—Vinblastine—breast cancer	6.59e-05	0.000638	CcSEcCtD
Theophylline—Abdominal pain upper—Epirubicin—breast cancer	6.59e-05	0.000638	CcSEcCtD
Theophylline—Insomnia—Fluorouracil—breast cancer	6.59e-05	0.000638	CcSEcCtD
Theophylline—Convulsion—Paclitaxel—breast cancer	6.59e-05	0.000637	CcSEcCtD
Theophylline—Hypokalaemia—Epirubicin—breast cancer	6.57e-05	0.000635	CcSEcCtD
Theophylline—Vomiting—Goserelin—breast cancer	6.55e-05	0.000633	CcSEcCtD
Theophylline—Alopecia—Docetaxel—breast cancer	6.54e-05	0.000633	CcSEcCtD
Theophylline—Pruritus—Vinorelbine—breast cancer	6.53e-05	0.000631	CcSEcCtD
Theophylline—Rash—Goserelin—breast cancer	6.49e-05	0.000628	CcSEcCtD
Theophylline—Hypersensitivity—Thiotepa—breast cancer	6.49e-05	0.000628	CcSEcCtD
Theophylline—Dermatitis—Goserelin—breast cancer	6.49e-05	0.000628	CcSEcCtD
Theophylline—Headache—Goserelin—breast cancer	6.45e-05	0.000624	CcSEcCtD
Theophylline—Anxiety—Paclitaxel—breast cancer	6.45e-05	0.000624	CcSEcCtD
Theophylline—Decreased appetite—Gemcitabine—breast cancer	6.44e-05	0.000623	CcSEcCtD
Theophylline—Nausea—Tamoxifen—breast cancer	6.41e-05	0.00062	CcSEcCtD
Theophylline—Arrhythmia—Capecitabine—breast cancer	6.4e-05	0.000619	CcSEcCtD
Theophylline—Decreased appetite—Fluorouracil—breast cancer	6.33e-05	0.000613	CcSEcCtD
Theophylline—Alopecia—Capecitabine—breast cancer	6.33e-05	0.000613	CcSEcCtD
Theophylline—Diarrhoea—Vinorelbine—breast cancer	6.31e-05	0.000611	CcSEcCtD
Theophylline—Nausea—Melphalan—breast cancer	6.27e-05	0.000607	CcSEcCtD
Theophylline—Pruritus—Thiotepa—breast cancer	6.23e-05	0.000603	CcSEcCtD
Theophylline—Gastrointestinal pain—Irinotecan—breast cancer	6.22e-05	0.000602	CcSEcCtD
Theophylline—Gastrointestinal pain—Mitoxantrone—breast cancer	6.22e-05	0.000602	CcSEcCtD
Theophylline—Caffeine—CYP3A4—breast cancer	6.21e-05	0.0165	CrCbGaD
Theophylline—Anaphylactic shock—Paclitaxel—breast cancer	6.2e-05	0.0006	CcSEcCtD
Theophylline—Infection—Paclitaxel—breast cancer	6.16e-05	0.000596	CcSEcCtD
Theophylline—Nausea—Goserelin—breast cancer	6.12e-05	0.000592	CcSEcCtD
Theophylline—Shock—Paclitaxel—breast cancer	6.1e-05	0.000591	CcSEcCtD
Theophylline—Dizziness—Vinorelbine—breast cancer	6.1e-05	0.00059	CcSEcCtD
Theophylline—Abdominal pain upper—Doxorubicin—breast cancer	6.1e-05	0.00059	CcSEcCtD
Theophylline—Nervous system disorder—Paclitaxel—breast cancer	6.08e-05	0.000589	CcSEcCtD
Theophylline—Hypokalaemia—Doxorubicin—breast cancer	6.08e-05	0.000588	CcSEcCtD
Theophylline—Tachycardia—Paclitaxel—breast cancer	6.06e-05	0.000586	CcSEcCtD
Theophylline—Urticaria—Mitoxantrone—breast cancer	6.04e-05	0.000585	CcSEcCtD
Theophylline—Diarrhoea—Thiotepa—breast cancer	6.03e-05	0.000583	CcSEcCtD
Theophylline—Abdominal pain—Mitoxantrone—breast cancer	6.01e-05	0.000582	CcSEcCtD
Theophylline—Abdominal pain—Irinotecan—breast cancer	6.01e-05	0.000582	CcSEcCtD
Theophylline—Body temperature increased—Irinotecan—breast cancer	6.01e-05	0.000582	CcSEcCtD
Theophylline—Body temperature increased—Mitoxantrone—breast cancer	6.01e-05	0.000582	CcSEcCtD
Theophylline—Anorexia—Paclitaxel—breast cancer	5.91e-05	0.000572	CcSEcCtD
Theophylline—Vomiting—Vinorelbine—breast cancer	5.87e-05	0.000567	CcSEcCtD
Theophylline—Body temperature increased—Gemcitabine—breast cancer	5.86e-05	0.000567	CcSEcCtD
Theophylline—Tremor—Capecitabine—breast cancer	5.85e-05	0.000565	CcSEcCtD
Theophylline—Dizziness—Thiotepa—breast cancer	5.83e-05	0.000564	CcSEcCtD
Theophylline—Rash—Vinorelbine—breast cancer	5.82e-05	0.000563	CcSEcCtD
Theophylline—Dermatitis—Vinorelbine—breast cancer	5.81e-05	0.000562	CcSEcCtD
Theophylline—Hypotension—Paclitaxel—breast cancer	5.8e-05	0.000561	CcSEcCtD
Theophylline—Urticaria—Fluorouracil—breast cancer	5.79e-05	0.00056	CcSEcCtD
Theophylline—Headache—Vinorelbine—breast cancer	5.78e-05	0.000559	CcSEcCtD
Theophylline—Body temperature increased—Fluorouracil—breast cancer	5.76e-05	0.000557	CcSEcCtD
Theophylline—Palpitations—Docetaxel—breast cancer	5.69e-05	0.000551	CcSEcCtD
Theophylline—Haematuria—Methotrexate—breast cancer	5.67e-05	0.000548	CcSEcCtD
Theophylline—Hyperglycaemia—Epirubicin—breast cancer	5.63e-05	0.000544	CcSEcCtD
Theophylline—Insomnia—Paclitaxel—breast cancer	5.61e-05	0.000543	CcSEcCtD
Theophylline—Hypersensitivity—Mitoxantrone—breast cancer	5.61e-05	0.000542	CcSEcCtD
Theophylline—Hypersensitivity—Irinotecan—breast cancer	5.61e-05	0.000542	CcSEcCtD
Theophylline—Vomiting—Thiotepa—breast cancer	5.6e-05	0.000542	CcSEcCtD
Theophylline—Convulsion—Docetaxel—breast cancer	5.58e-05	0.00054	CcSEcCtD
Theophylline—Rash—Thiotepa—breast cancer	5.55e-05	0.000537	CcSEcCtD
Theophylline—Dermatitis—Thiotepa—breast cancer	5.55e-05	0.000537	CcSEcCtD
Theophylline—Headache—Thiotepa—breast cancer	5.52e-05	0.000534	CcSEcCtD
Theophylline—Palpitations—Capecitabine—breast cancer	5.51e-05	0.000533	CcSEcCtD
Theophylline—Nausea—Vinorelbine—breast cancer	5.48e-05	0.00053	CcSEcCtD
Theophylline—Decreased appetite—Paclitaxel—breast cancer	5.39e-05	0.000522	CcSEcCtD
Theophylline—Hypersensitivity—Fluorouracil—breast cancer	5.37e-05	0.000519	CcSEcCtD
Theophylline—Haematuria—Epirubicin—breast cancer	5.3e-05	0.000513	CcSEcCtD
Theophylline—Anxiety—Capecitabine—breast cancer	5.29e-05	0.000512	CcSEcCtD
Theophylline—Anaphylactic shock—Docetaxel—breast cancer	5.26e-05	0.000509	CcSEcCtD
Theophylline—Pruritus—Gemcitabine—breast cancer	5.24e-05	0.000507	CcSEcCtD
Theophylline—Nausea—Thiotepa—breast cancer	5.23e-05	0.000506	CcSEcCtD
Theophylline—Infection—Docetaxel—breast cancer	5.22e-05	0.000505	CcSEcCtD
Theophylline—Hyperglycaemia—Doxorubicin—breast cancer	5.21e-05	0.000504	CcSEcCtD
Theophylline—Diarrhoea—Mitoxantrone—breast cancer	5.21e-05	0.000504	CcSEcCtD
Theophylline—Diarrhoea—Irinotecan—breast cancer	5.21e-05	0.000504	CcSEcCtD
Theophylline—Shock—Docetaxel—breast cancer	5.17e-05	0.000501	CcSEcCtD
Theophylline—Caffeine—ABCB1—breast cancer	5.17e-05	0.0138	CrCbGaD
Theophylline—Nervous system disorder—Docetaxel—breast cancer	5.16e-05	0.000499	CcSEcCtD
Theophylline—Pruritus—Fluorouracil—breast cancer	5.16e-05	0.000499	CcSEcCtD
Theophylline—Tachycardia—Docetaxel—breast cancer	5.13e-05	0.000497	CcSEcCtD
Theophylline—Gastrointestinal pain—Paclitaxel—breast cancer	5.07e-05	0.000491	CcSEcCtD
Theophylline—Diarrhoea—Gemcitabine—breast cancer	5.07e-05	0.00049	CcSEcCtD
Theophylline—Infection—Capecitabine—breast cancer	5.06e-05	0.000489	CcSEcCtD
Theophylline—Dizziness—Irinotecan—breast cancer	5.03e-05	0.000487	CcSEcCtD
Theophylline—Anorexia—Docetaxel—breast cancer	5.01e-05	0.000485	CcSEcCtD
Theophylline—Shock—Capecitabine—breast cancer	5.01e-05	0.000485	CcSEcCtD
Theophylline—Nervous system disorder—Capecitabine—breast cancer	4.99e-05	0.000483	CcSEcCtD
Theophylline—Diarrhoea—Fluorouracil—breast cancer	4.99e-05	0.000482	CcSEcCtD
Theophylline—Tachycardia—Capecitabine—breast cancer	4.97e-05	0.000481	CcSEcCtD
Theophylline—Urticaria—Paclitaxel—breast cancer	4.93e-05	0.000477	CcSEcCtD
Theophylline—Hypotension—Docetaxel—breast cancer	4.91e-05	0.000475	CcSEcCtD
Theophylline—Haematuria—Doxorubicin—breast cancer	4.91e-05	0.000475	CcSEcCtD
Theophylline—Abdominal pain—Paclitaxel—breast cancer	4.91e-05	0.000474	CcSEcCtD
Theophylline—Body temperature increased—Paclitaxel—breast cancer	4.91e-05	0.000474	CcSEcCtD
Theophylline—Anorexia—Capecitabine—breast cancer	4.85e-05	0.00047	CcSEcCtD
Theophylline—Vomiting—Mitoxantrone—breast cancer	4.84e-05	0.000468	CcSEcCtD
Theophylline—Vomiting—Irinotecan—breast cancer	4.84e-05	0.000468	CcSEcCtD
Theophylline—Dizziness—Fluorouracil—breast cancer	4.82e-05	0.000466	CcSEcCtD
Theophylline—Rash—Mitoxantrone—breast cancer	4.8e-05	0.000464	CcSEcCtD
Theophylline—Rash—Irinotecan—breast cancer	4.8e-05	0.000464	CcSEcCtD
Theophylline—Dermatitis—Mitoxantrone—breast cancer	4.79e-05	0.000464	CcSEcCtD
Theophylline—Dermatitis—Irinotecan—breast cancer	4.79e-05	0.000464	CcSEcCtD
Theophylline—Headache—Mitoxantrone—breast cancer	4.77e-05	0.000461	CcSEcCtD
Theophylline—Headache—Irinotecan—breast cancer	4.77e-05	0.000461	CcSEcCtD
Theophylline—Hypotension—Capecitabine—breast cancer	4.76e-05	0.00046	CcSEcCtD
Theophylline—Insomnia—Docetaxel—breast cancer	4.76e-05	0.00046	CcSEcCtD
Theophylline—Alopecia—Methotrexate—breast cancer	4.71e-05	0.000456	CcSEcCtD
Theophylline—Vomiting—Gemcitabine—breast cancer	4.71e-05	0.000456	CcSEcCtD
Theophylline—Rash—Gemcitabine—breast cancer	4.67e-05	0.000452	CcSEcCtD
Theophylline—Dermatitis—Gemcitabine—breast cancer	4.67e-05	0.000452	CcSEcCtD
Theophylline—Headache—Gemcitabine—breast cancer	4.64e-05	0.000449	CcSEcCtD
Theophylline—Flushing—Epirubicin—breast cancer	4.63e-05	0.000448	CcSEcCtD
Theophylline—Vomiting—Fluorouracil—breast cancer	4.63e-05	0.000448	CcSEcCtD
Theophylline—Insomnia—Capecitabine—breast cancer	4.61e-05	0.000445	CcSEcCtD
Theophylline—Rash—Fluorouracil—breast cancer	4.59e-05	0.000444	CcSEcCtD
Theophylline—Dermatitis—Fluorouracil—breast cancer	4.59e-05	0.000444	CcSEcCtD
Theophylline—Decreased appetite—Docetaxel—breast cancer	4.57e-05	0.000442	CcSEcCtD
Theophylline—Hypersensitivity—Paclitaxel—breast cancer	4.57e-05	0.000442	CcSEcCtD
Theophylline—Headache—Fluorouracil—breast cancer	4.56e-05	0.000442	CcSEcCtD
Theophylline—Nausea—Irinotecan—breast cancer	4.52e-05	0.000437	CcSEcCtD
Theophylline—Nausea—Mitoxantrone—breast cancer	4.52e-05	0.000437	CcSEcCtD
Theophylline—Arrhythmia—Epirubicin—breast cancer	4.46e-05	0.000431	CcSEcCtD
Theophylline—Decreased appetite—Capecitabine—breast cancer	4.43e-05	0.000428	CcSEcCtD
Theophylline—Alopecia—Epirubicin—breast cancer	4.41e-05	0.000427	CcSEcCtD
Theophylline—Nausea—Gemcitabine—breast cancer	4.4e-05	0.000426	CcSEcCtD
Theophylline—Pruritus—Paclitaxel—breast cancer	4.39e-05	0.000425	CcSEcCtD
Theophylline—Nausea—Fluorouracil—breast cancer	4.33e-05	0.000419	CcSEcCtD
Theophylline—Gastrointestinal pain—Docetaxel—breast cancer	4.3e-05	0.000416	CcSEcCtD
Theophylline—Flushing—Doxorubicin—breast cancer	4.29e-05	0.000415	CcSEcCtD
Theophylline—Tension—Epirubicin—breast cancer	4.27e-05	0.000413	CcSEcCtD
Theophylline—Diarrhoea—Paclitaxel—breast cancer	4.25e-05	0.000411	CcSEcCtD
Theophylline—Nervousness—Epirubicin—breast cancer	4.22e-05	0.000408	CcSEcCtD
Theophylline—Gastrointestinal pain—Capecitabine—breast cancer	4.16e-05	0.000403	CcSEcCtD
Theophylline—Body temperature increased—Docetaxel—breast cancer	4.16e-05	0.000402	CcSEcCtD
Theophylline—Abdominal pain—Docetaxel—breast cancer	4.16e-05	0.000402	CcSEcCtD
Theophylline—Arrhythmia—Doxorubicin—breast cancer	4.13e-05	0.000399	CcSEcCtD
Theophylline—Dizziness—Paclitaxel—breast cancer	4.1e-05	0.000397	CcSEcCtD
Theophylline—Alopecia—Doxorubicin—breast cancer	4.08e-05	0.000395	CcSEcCtD
Theophylline—Urticaria—Capecitabine—breast cancer	4.05e-05	0.000391	CcSEcCtD
Theophylline—Abdominal pain—Capecitabine—breast cancer	4.03e-05	0.000389	CcSEcCtD
Theophylline—Body temperature increased—Capecitabine—breast cancer	4.03e-05	0.000389	CcSEcCtD
Theophylline—Convulsion—Methotrexate—breast cancer	4.02e-05	0.000389	CcSEcCtD
Theophylline—Agitation—Epirubicin—breast cancer	3.99e-05	0.000386	CcSEcCtD
Theophylline—Tension—Doxorubicin—breast cancer	3.95e-05	0.000382	CcSEcCtD
Theophylline—Vomiting—Paclitaxel—breast cancer	3.95e-05	0.000382	CcSEcCtD
Theophylline—Rash—Paclitaxel—breast cancer	3.91e-05	0.000378	CcSEcCtD
Theophylline—Dermatitis—Paclitaxel—breast cancer	3.91e-05	0.000378	CcSEcCtD
Theophylline—Nervousness—Doxorubicin—breast cancer	3.91e-05	0.000378	CcSEcCtD
Theophylline—Headache—Paclitaxel—breast cancer	3.89e-05	0.000376	CcSEcCtD
Theophylline—Hypersensitivity—Docetaxel—breast cancer	3.87e-05	0.000375	CcSEcCtD
Theophylline—Palpitations—Epirubicin—breast cancer	3.84e-05	0.000372	CcSEcCtD
Theophylline—Anaphylactic shock—Methotrexate—breast cancer	3.79e-05	0.000367	CcSEcCtD
Theophylline—Convulsion—Epirubicin—breast cancer	3.77e-05	0.000364	CcSEcCtD
Theophylline—Infection—Methotrexate—breast cancer	3.77e-05	0.000364	CcSEcCtD
Theophylline—Hypersensitivity—Capecitabine—breast cancer	3.75e-05	0.000363	CcSEcCtD
Theophylline—Pruritus—Docetaxel—breast cancer	3.72e-05	0.00036	CcSEcCtD
Theophylline—Nervous system disorder—Methotrexate—breast cancer	3.72e-05	0.00036	CcSEcCtD
Theophylline—Agitation—Doxorubicin—breast cancer	3.7e-05	0.000358	CcSEcCtD
Theophylline—Anxiety—Epirubicin—breast cancer	3.69e-05	0.000357	CcSEcCtD
Theophylline—Nausea—Paclitaxel—breast cancer	3.69e-05	0.000357	CcSEcCtD
Theophylline—Anorexia—Methotrexate—breast cancer	3.61e-05	0.00035	CcSEcCtD
Theophylline—Pruritus—Capecitabine—breast cancer	3.6e-05	0.000348	CcSEcCtD
Theophylline—Diarrhoea—Docetaxel—breast cancer	3.6e-05	0.000348	CcSEcCtD
Theophylline—Palpitations—Doxorubicin—breast cancer	3.55e-05	0.000344	CcSEcCtD
Theophylline—Anaphylactic shock—Epirubicin—breast cancer	3.55e-05	0.000343	CcSEcCtD
Theophylline—Hypotension—Methotrexate—breast cancer	3.54e-05	0.000343	CcSEcCtD
Theophylline—Infection—Epirubicin—breast cancer	3.52e-05	0.000341	CcSEcCtD
Theophylline—Shock—Epirubicin—breast cancer	3.49e-05	0.000338	CcSEcCtD
Theophylline—Convulsion—Doxorubicin—breast cancer	3.48e-05	0.000337	CcSEcCtD
Theophylline—Diarrhoea—Capecitabine—breast cancer	3.48e-05	0.000337	CcSEcCtD
Theophylline—Nervous system disorder—Epirubicin—breast cancer	3.48e-05	0.000337	CcSEcCtD
Theophylline—Dizziness—Docetaxel—breast cancer	3.48e-05	0.000336	CcSEcCtD
Theophylline—Tachycardia—Epirubicin—breast cancer	3.46e-05	0.000335	CcSEcCtD
Theophylline—Insomnia—Methotrexate—breast cancer	3.43e-05	0.000332	CcSEcCtD
Theophylline—Anxiety—Doxorubicin—breast cancer	3.41e-05	0.00033	CcSEcCtD
Theophylline—Anorexia—Epirubicin—breast cancer	3.38e-05	0.000327	CcSEcCtD
Theophylline—Dizziness—Capecitabine—breast cancer	3.37e-05	0.000326	CcSEcCtD
Theophylline—Vomiting—Docetaxel—breast cancer	3.34e-05	0.000323	CcSEcCtD
Theophylline—Rash—Docetaxel—breast cancer	3.32e-05	0.000321	CcSEcCtD
Theophylline—Hypotension—Epirubicin—breast cancer	3.31e-05	0.000321	CcSEcCtD
Theophylline—Dermatitis—Docetaxel—breast cancer	3.31e-05	0.00032	CcSEcCtD
Theophylline—Decreased appetite—Methotrexate—breast cancer	3.3e-05	0.000319	CcSEcCtD
Theophylline—Headache—Docetaxel—breast cancer	3.29e-05	0.000319	CcSEcCtD
Theophylline—Anaphylactic shock—Doxorubicin—breast cancer	3.28e-05	0.000318	CcSEcCtD
Theophylline—Infection—Doxorubicin—breast cancer	3.26e-05	0.000315	CcSEcCtD
Theophylline—Vomiting—Capecitabine—breast cancer	3.24e-05	0.000313	CcSEcCtD
Theophylline—Shock—Doxorubicin—breast cancer	3.23e-05	0.000312	CcSEcCtD
Theophylline—Nervous system disorder—Doxorubicin—breast cancer	3.22e-05	0.000311	CcSEcCtD
Theophylline—Rash—Capecitabine—breast cancer	3.21e-05	0.000311	CcSEcCtD
Theophylline—Insomnia—Epirubicin—breast cancer	3.21e-05	0.00031	CcSEcCtD
Theophylline—Dermatitis—Capecitabine—breast cancer	3.21e-05	0.00031	CcSEcCtD
Theophylline—Tachycardia—Doxorubicin—breast cancer	3.2e-05	0.00031	CcSEcCtD
Theophylline—Headache—Capecitabine—breast cancer	3.19e-05	0.000309	CcSEcCtD
Theophylline—Anorexia—Doxorubicin—breast cancer	3.13e-05	0.000303	CcSEcCtD
Theophylline—Nausea—Docetaxel—breast cancer	3.12e-05	0.000302	CcSEcCtD
Theophylline—Gastrointestinal pain—Methotrexate—breast cancer	3.1e-05	0.0003	CcSEcCtD
Theophylline—Decreased appetite—Epirubicin—breast cancer	3.08e-05	0.000298	CcSEcCtD
Theophylline—Hypotension—Doxorubicin—breast cancer	3.07e-05	0.000297	CcSEcCtD
Theophylline—Nausea—Capecitabine—breast cancer	3.02e-05	0.000293	CcSEcCtD
Theophylline—Urticaria—Methotrexate—breast cancer	3.01e-05	0.000291	CcSEcCtD
Theophylline—Abdominal pain—Methotrexate—breast cancer	3e-05	0.00029	CcSEcCtD
Theophylline—Body temperature increased—Methotrexate—breast cancer	3e-05	0.00029	CcSEcCtD
Theophylline—Insomnia—Doxorubicin—breast cancer	2.97e-05	0.000287	CcSEcCtD
Theophylline—Gastrointestinal pain—Epirubicin—breast cancer	2.9e-05	0.000281	CcSEcCtD
Theophylline—Decreased appetite—Doxorubicin—breast cancer	2.85e-05	0.000276	CcSEcCtD
Theophylline—Urticaria—Epirubicin—breast cancer	2.82e-05	0.000273	CcSEcCtD
Theophylline—Abdominal pain—Epirubicin—breast cancer	2.8e-05	0.000271	CcSEcCtD
Theophylline—Body temperature increased—Epirubicin—breast cancer	2.8e-05	0.000271	CcSEcCtD
Theophylline—Hypersensitivity—Methotrexate—breast cancer	2.79e-05	0.00027	CcSEcCtD
Theophylline—Gastrointestinal pain—Doxorubicin—breast cancer	2.68e-05	0.00026	CcSEcCtD
Theophylline—Pruritus—Methotrexate—breast cancer	2.68e-05	0.000259	CcSEcCtD
Theophylline—Hypersensitivity—Epirubicin—breast cancer	2.61e-05	0.000253	CcSEcCtD
Theophylline—Urticaria—Doxorubicin—breast cancer	2.61e-05	0.000252	CcSEcCtD
Theophylline—Abdominal pain—Doxorubicin—breast cancer	2.59e-05	0.000251	CcSEcCtD
Theophylline—Body temperature increased—Doxorubicin—breast cancer	2.59e-05	0.000251	CcSEcCtD
Theophylline—Diarrhoea—Methotrexate—breast cancer	2.59e-05	0.000251	CcSEcCtD
Theophylline—Pruritus—Epirubicin—breast cancer	2.51e-05	0.000243	CcSEcCtD
Theophylline—Dizziness—Methotrexate—breast cancer	2.51e-05	0.000242	CcSEcCtD
Theophylline—Diarrhoea—Epirubicin—breast cancer	2.43e-05	0.000235	CcSEcCtD
Theophylline—Hypersensitivity—Doxorubicin—breast cancer	2.42e-05	0.000234	CcSEcCtD
Theophylline—Vomiting—Methotrexate—breast cancer	2.41e-05	0.000233	CcSEcCtD
Theophylline—Rash—Methotrexate—breast cancer	2.39e-05	0.000231	CcSEcCtD
Theophylline—Dermatitis—Methotrexate—breast cancer	2.39e-05	0.000231	CcSEcCtD
Theophylline—Headache—Methotrexate—breast cancer	2.37e-05	0.00023	CcSEcCtD
Theophylline—Dizziness—Epirubicin—breast cancer	2.35e-05	0.000227	CcSEcCtD
Theophylline—Pruritus—Doxorubicin—breast cancer	2.32e-05	0.000225	CcSEcCtD
Theophylline—Vomiting—Epirubicin—breast cancer	2.26e-05	0.000218	CcSEcCtD
Theophylline—Nausea—Methotrexate—breast cancer	2.25e-05	0.000218	CcSEcCtD
Theophylline—Diarrhoea—Doxorubicin—breast cancer	2.25e-05	0.000217	CcSEcCtD
Theophylline—Rash—Epirubicin—breast cancer	2.24e-05	0.000216	CcSEcCtD
Theophylline—Dermatitis—Epirubicin—breast cancer	2.23e-05	0.000216	CcSEcCtD
Theophylline—Headache—Epirubicin—breast cancer	2.22e-05	0.000215	CcSEcCtD
Theophylline—Dizziness—Doxorubicin—breast cancer	2.17e-05	0.00021	CcSEcCtD
Theophylline—Nausea—Epirubicin—breast cancer	2.11e-05	0.000204	CcSEcCtD
Theophylline—Vomiting—Doxorubicin—breast cancer	2.09e-05	0.000202	CcSEcCtD
Theophylline—Rash—Doxorubicin—breast cancer	2.07e-05	0.0002	CcSEcCtD
Theophylline—Dermatitis—Doxorubicin—breast cancer	2.07e-05	0.0002	CcSEcCtD
Theophylline—Headache—Doxorubicin—breast cancer	2.06e-05	0.000199	CcSEcCtD
Theophylline—Nausea—Doxorubicin—breast cancer	1.95e-05	0.000189	CcSEcCtD
Theophylline—CYP1B1—Metabolism—PIK3CB—breast cancer	1.27e-06	1.14e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.27e-06	1.14e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.27e-06	1.14e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PIK3CA—breast cancer	1.27e-06	1.14e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—AKT1—breast cancer	1.26e-06	1.14e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP2D6—breast cancer	1.26e-06	1.14e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VEGFA—breast cancer	1.26e-06	1.14e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—NCOR1—breast cancer	1.26e-06	1.13e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GSTM1—breast cancer	1.26e-06	1.13e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PLA2G4A—breast cancer	1.26e-06	1.13e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTGS2—breast cancer	1.26e-06	1.13e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.26e-06	1.13e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HRAS—breast cancer	1.25e-06	1.13e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—STAT3—breast cancer	1.25e-06	1.12e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—AKT1—breast cancer	1.25e-06	1.12e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—IL6—breast cancer	1.24e-06	1.12e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NCOA2—breast cancer	1.24e-06	1.12e-05	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—AKT1—breast cancer	1.24e-06	1.11e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL6—breast cancer	1.23e-06	1.11e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—NCOA1—breast cancer	1.23e-06	1.11e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PIK3CA—breast cancer	1.23e-06	1.11e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HRAS—breast cancer	1.23e-06	1.11e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—breast cancer	1.22e-06	1.1e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—NCOA1—breast cancer	1.22e-06	1.1e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP19A1—breast cancer	1.22e-06	1.1e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—STK11—breast cancer	1.22e-06	1.1e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—MTHFR—breast cancer	1.21e-06	1.09e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GPX1—breast cancer	1.21e-06	1.09e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP19A1—breast cancer	1.2e-06	1.09e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—STK11—breast cancer	1.2e-06	1.09e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—SRC—breast cancer	1.2e-06	1.08e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—FASN—breast cancer	1.2e-06	1.08e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—MED12—breast cancer	1.2e-06	1.08e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—DPYD—breast cancer	1.2e-06	1.08e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—BCHE—breast cancer	1.2e-06	1.08e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL6—breast cancer	1.2e-06	1.08e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CYP1A1—breast cancer	1.19e-06	1.08e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MAPK3—breast cancer	1.19e-06	1.07e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—breast cancer	1.19e-06	1.07e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—CAV1—breast cancer	1.19e-06	1.07e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PIK3CA—breast cancer	1.18e-06	1.07e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ERCC2—breast cancer	1.18e-06	1.07e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—SLC5A5—breast cancer	1.18e-06	1.07e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALDOA—breast cancer	1.18e-06	1.06e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL6—breast cancer	1.18e-06	1.06e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VEGFA—breast cancer	1.17e-06	1.06e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PIK3CA—breast cancer	1.17e-06	1.06e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HRAS—breast cancer	1.17e-06	1.06e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—STAT3—breast cancer	1.16e-06	1.05e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MYC—breast cancer	1.16e-06	1.05e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TGFB1—breast cancer	1.16e-06	1.04e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—AKT1—breast cancer	1.15e-06	1.03e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NCOA3—breast cancer	1.15e-06	1.03e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—breast cancer	1.15e-06	1.03e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NQO1—breast cancer	1.14e-06	1.03e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—SLC2A1—breast cancer	1.14e-06	1.03e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HRAS—breast cancer	1.14e-06	1.03e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—AKT1—breast cancer	1.14e-06	1.03e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SLC2A2—breast cancer	1.14e-06	1.03e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—EGFR—breast cancer	1.13e-06	1.02e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—breast cancer	1.13e-06	1.02e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.13e-06	1.02e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—COMT—breast cancer	1.13e-06	1.02e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTP1—breast cancer	1.12e-06	1.01e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL6—breast cancer	1.12e-06	1.01e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—COMT—breast cancer	1.12e-06	1.01e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—CAV1—breast cancer	1.12e-06	1.01e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.12e-06	1.01e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ABCG2—breast cancer	1.11e-06	1.01e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CPT1A—breast cancer	1.11e-06	1.01e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—MTR—breast cancer	1.11e-06	1.01e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTP1—breast cancer	1.11e-06	1.01e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP3A4—breast cancer	1.11e-06	1e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—MTHFR—breast cancer	1.11e-06	1e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—HMOX1—breast cancer	1.11e-06	1e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.11e-06	9.99e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MAPK3—breast cancer	1.11e-06	9.99e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ITPR1—breast cancer	1.11e-06	9.98e-06	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—AKT1—breast cancer	1.1e-06	9.95e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—HMOX1—breast cancer	1.1e-06	9.91e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ITPR1—breast cancer	1.1e-06	9.89e-06	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HRAS—breast cancer	1.1e-06	9.88e-06	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTEN—breast cancer	1.1e-06	9.88e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP1B1—breast cancer	1.09e-06	9.87e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HPGDS—breast cancer	1.09e-06	9.86e-06	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL6—breast cancer	1.09e-06	9.83e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HBA1—breast cancer	1.09e-06	9.8e-06	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—AKT1—breast cancer	1.09e-06	9.79e-06	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HRAS—breast cancer	1.08e-06	9.77e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CG—breast cancer	1.08e-06	9.75e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MYC—breast cancer	1.08e-06	9.72e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TGFB1—breast cancer	1.07e-06	9.69e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.07e-06	9.68e-06	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KRAS—breast cancer	1.07e-06	9.66e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.07e-06	9.64e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ABCB1—breast cancer	1.06e-06	9.6e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTT1—breast cancer	1.06e-06	9.56e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ACHE—breast cancer	1.06e-06	9.56e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ABCB1—breast cancer	1.06e-06	9.51e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EGFR—breast cancer	1.05e-06	9.5e-06	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL6—breast cancer	1.05e-06	9.46e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—TYMS—breast cancer	1.05e-06	9.43e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NCOA1—breast cancer	1.04e-06	9.42e-06	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL6—breast cancer	1.04e-06	9.35e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—TYMS—breast cancer	1.04e-06	9.34e-06	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—AKT1—breast cancer	1.03e-06	9.32e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTM1—breast cancer	1.03e-06	9.32e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.03e-06	9.32e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—NCOR1—breast cancer	1.03e-06	9.32e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—STK11—breast cancer	1.03e-06	9.28e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP19A1—breast cancer	1.03e-06	9.28e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CAV1—breast cancer	1.03e-06	9.25e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—NCOR1—breast cancer	1.02e-06	9.24e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTM1—breast cancer	1.02e-06	9.24e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.02e-06	9.24e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CG—breast cancer	1.02e-06	9.19e-06	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—AKT1—breast cancer	1.01e-06	9.07e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP17A1—breast cancer	1e-06	9.05e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KRAS—breast cancer	9.96e-07	8.98e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTGS1—breast cancer	9.94e-07	8.96e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ENO1—breast cancer	9.94e-07	8.96e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GPX1—breast cancer	9.89e-07	8.92e-06	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PIK3CA—breast cancer	9.84e-07	8.87e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GPX1—breast cancer	9.81e-07	8.84e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.8e-07	8.84e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP1A1—breast cancer	9.79e-07	8.83e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP2D6—breast cancer	9.75e-07	8.79e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ERCC2—breast cancer	9.71e-07	8.76e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP1A1—breast cancer	9.71e-07	8.76e-06	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—AKT1—breast cancer	9.68e-07	8.73e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	9.66e-07	8.71e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ERCC2—breast cancer	9.63e-07	8.68e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—COMT—breast cancer	9.57e-07	8.63e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NCOA2—breast cancer	9.57e-07	8.63e-06	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—AKT1—breast cancer	9.56e-07	8.62e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTP1—breast cancer	9.52e-07	8.59e-06	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—breast cancer	9.52e-07	8.58e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CD—breast cancer	9.5e-07	8.57e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—HMOX1—breast cancer	9.39e-07	8.47e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ALB—breast cancer	9.38e-07	8.46e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ITPR1—breast cancer	9.37e-07	8.45e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CG—breast cancer	9.35e-07	8.43e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—FASN—breast cancer	9.28e-07	8.37e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—BCHE—breast cancer	9.24e-07	8.33e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PIK3CA—breast cancer	9.15e-07	8.25e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—MTHFR—breast cancer	9.13e-07	8.23e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SLC5A5—breast cancer	9.13e-07	8.23e-06	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HRAS—breast cancer	9.1e-07	8.21e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—MTHFR—breast cancer	9.05e-07	8.16e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ABCB1—breast cancer	9.02e-07	8.13e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—NOS3—breast cancer	8.97e-07	8.09e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CD—breast cancer	8.96e-07	8.08e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—TYMS—breast cancer	8.85e-07	7.98e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—breast cancer	8.85e-07	7.98e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ALB—breast cancer	8.85e-07	7.98e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SLC2A1—breast cancer	8.81e-07	7.95e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NQO1—breast cancer	8.81e-07	7.95e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTM1—breast cancer	8.75e-07	7.89e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NCOR1—breast cancer	8.75e-07	7.89e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PLA2G4A—breast cancer	8.75e-07	7.89e-06	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL6—breast cancer	8.71e-07	7.86e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HRAS—breast cancer	8.46e-07	7.63e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—NOS3—breast cancer	8.46e-07	7.63e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP1B1—breast cancer	8.45e-07	7.62e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CAV1—breast cancer	8.42e-07	7.59e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GPX1—breast cancer	8.38e-07	7.56e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CAV1—breast cancer	8.35e-07	7.53e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP1A1—breast cancer	8.3e-07	7.48e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HSP90AA1—breast cancer	8.29e-07	7.47e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CB—breast cancer	8.28e-07	7.47e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ERCC2—breast cancer	8.23e-07	7.42e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CD—breast cancer	8.22e-07	7.41e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTGS2—breast cancer	8.21e-07	7.4e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ALB—breast cancer	8.11e-07	7.31e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL6—breast cancer	8.1e-07	7.3e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NCOA1—breast cancer	8.06e-07	7.27e-06	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—AKT1—breast cancer	8.04e-07	7.25e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.98e-07	7.19e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—STK11—breast cancer	7.94e-07	7.16e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP19A1—breast cancer	7.94e-07	7.16e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CB—breast cancer	7.81e-07	7.04e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—NOS3—breast cancer	7.76e-07	6.99e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTGS2—breast cancer	7.74e-07	6.98e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—MTHFR—breast cancer	7.74e-07	6.98e-06	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CA—breast cancer	7.73e-07	6.97e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CG—breast cancer	7.67e-07	6.92e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CG—breast cancer	7.61e-07	6.86e-06	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—AKT1—breast cancer	7.47e-07	6.74e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—COMT—breast cancer	7.39e-07	6.66e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTP1—breast cancer	7.35e-07	6.63e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HMOX1—breast cancer	7.25e-07	6.54e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ITPR1—breast cancer	7.23e-07	6.52e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CB—breast cancer	7.16e-07	6.46e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTEN—breast cancer	7.16e-07	6.45e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CAV1—breast cancer	7.14e-07	6.43e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTGS2—breast cancer	7.1e-07	6.4e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ABCB1—breast cancer	6.96e-07	6.27e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—TYMS—breast cancer	6.83e-07	6.16e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.82e-07	6.15e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NCOR1—breast cancer	6.76e-07	6.09e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PLA2G4A—breast cancer	6.76e-07	6.09e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTM1—breast cancer	6.76e-07	6.09e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTEN—breast cancer	6.75e-07	6.09e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CD—breast cancer	6.74e-07	6.08e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CD—breast cancer	6.69e-07	6.03e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ALB—breast cancer	6.66e-07	6e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ALB—breast cancer	6.6e-07	5.95e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CG—breast cancer	6.5e-07	5.86e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GPX1—breast cancer	6.47e-07	5.83e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP1A1—breast cancer	6.4e-07	5.77e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—NOS3—breast cancer	6.37e-07	5.74e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ERCC2—breast cancer	6.35e-07	5.73e-06	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—AKT1—breast cancer	6.32e-07	5.7e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—NOS3—breast cancer	6.31e-07	5.69e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTEN—breast cancer	6.19e-07	5.58e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—MTHFR—breast cancer	5.97e-07	5.38e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CB—breast cancer	5.88e-07	5.3e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CB—breast cancer	5.83e-07	5.25e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTGS2—breast cancer	5.82e-07	5.25e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTGS2—breast cancer	5.77e-07	5.21e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CD—breast cancer	5.71e-07	5.15e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ALB—breast cancer	5.64e-07	5.09e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CAV1—breast cancer	5.51e-07	4.97e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NOS3—breast cancer	5.4e-07	4.86e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTEN—breast cancer	5.08e-07	4.58e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CA—breast cancer	5.05e-07	4.55e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTEN—breast cancer	5.04e-07	4.54e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CG—breast cancer	5.02e-07	4.52e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CB—breast cancer	4.98e-07	4.49e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTGS2—breast cancer	4.93e-07	4.45e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CA—breast cancer	4.76e-07	4.29e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CD—breast cancer	4.41e-07	3.98e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CA—breast cancer	4.37e-07	3.94e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALB—breast cancer	4.35e-07	3.93e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTEN—breast cancer	4.3e-07	3.88e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NOS3—breast cancer	4.16e-07	3.75e-06	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—AKT1—breast cancer	4.13e-07	3.72e-06	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—AKT1—breast cancer	3.89e-07	3.51e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CB—breast cancer	3.84e-07	3.47e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTGS2—breast cancer	3.81e-07	3.43e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CA—breast cancer	3.58e-07	3.23e-06	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—AKT1—breast cancer	3.57e-07	3.22e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CA—breast cancer	3.55e-07	3.2e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTEN—breast cancer	3.32e-07	2.99e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CA—breast cancer	3.04e-07	2.74e-06	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AKT1—breast cancer	2.93e-07	2.64e-06	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AKT1—breast cancer	2.9e-07	2.62e-06	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AKT1—breast cancer	2.48e-07	2.24e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CA—breast cancer	2.34e-07	2.11e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKT1—breast cancer	1.91e-07	1.73e-06	CbGpPWpGaD
